Peptide Amphiphiles as Biodegradable Adjuvants for Efficient Retroviral Gene Delivery.
Kübra KaygisizLena Rauch-WirthAysenur IscenJan HartenfelsKurt KremerJan MünchChristopher V SynatschkeTanja WeilPublished in: Advanced healthcare materials (2023)
Retroviral gene delivery is the key technique for in vitro and ex vivo gene therapy. However, inefficient virion-cell attachment resulting in low gene transduction efficacy remains a major challenge in clinical applications. Adjuvants for ex vivo therapy settings need to increase transduction efficiency while being easily removed or degraded post-transduction to prevent the risk of venous embolism after infusing the transduced cells back to the bloodstream of patients, yet no such peptide system have been reported thus far. In this study, we introduce peptide amphiphiles (PAs) with a hydrophobic fatty acid and a hydrophilic peptide moiety that reveal enhanced viral transduction efficiency. The PAs form β-sheet-rich fibrils that assemble into positively charged aggregates, promoting virus adhesion to the cell membrane. The block-type amphiphilic sequence arrangement in the PAs ensures efficient cell-virus interaction and biodegradability. Good biodegradability is observed for fibrils forming small aggregates and we show via molecular dynamics simulations that the fibril-fibril interactions of PAs are governed by fibril surface hydrophobicity. Our findings establish PAs as additives in retroviral gene transfer, rivalling commercially available transduction enhancers in efficiency and degradability with promising translational options in clinical gene therapy applications. This article is protected by copyright. All rights reserved.
Keyphrases
- gene therapy
- molecular dynamics simulations
- single cell
- fatty acid
- genome wide
- cell therapy
- end stage renal disease
- ejection fraction
- newly diagnosed
- sars cov
- gene expression
- oxidative stress
- genome wide identification
- mesenchymal stem cells
- prognostic factors
- liquid chromatography
- transcription factor
- amino acid
- signaling pathway
- cell cycle arrest
- patient reported
- smoking cessation
- candida albicans
- replacement therapy
- tandem mass spectrometry